Engineering genetic approaches to develop a CAR-T cell therapy efficaciously targeting #SolidTumor doi.org/10.1016/j.cc... @DJPowellLab #NeoCARs #CellTherapy #CARTCell #GeneTherapy #ImmunoTherapy #Oncology #TranslationalScience

Dissecting LUSC heterogeneity with scRNA-seq: See how researchers identified KLF4-driven hillock-like states in our new #solidtumor profiling note. 46743515.fs1.hubspotusercontent-na1.net/hubfs/467435.... #CancerResearch #Genomics #SingleCell #SigniosBio #ScienceOfSignals

Submit your diagnostic advancements to JMD for consideration today! JMD is the official publication of @ampath.bsky.social.

editorialmanager.com/jmdi/default...

#SolidTumor #InfectiousDisease #Informatics #Hematopathology #Genetics

Don’t miss the upcoming FREE webinar Cases in Precision Oncology: Complex In-frame DELINS in Cancer on June 24 at 11am ET. Featuring expert insights from
@mayoclinic.org. Details: bit.ly/43AnZMa #Genomics #SolidTumor #Oncology #MolecularTumorBoard

Consider @JMDiagn for your next manuscript in #moldx and #molpath. We consider papers looking to improve diagnosis of #genetic conditions, #infectiousdisease, #hemathopathology disorders, #solidtumor, and healthcare #informatics.

Submission is free: https://loom.ly/LylFFhM

PEM in MSI and dMMR advanced solid tumors - Nieves Martinez Lago
@dramartinezlago.bsky.social

oncodaily.com/science/2541...

#Cancer #CancerResearch #SolidTumor #ClinicalTrial #Medicine #Health #Oncology #OncoDaily

https://www.editorialmanager.com/jmdi/default2.aspx

#solidtumor #oncology #cancer

Consider @jmdiagn.bsky.social for your next manuscript containing diagnostic advances in #solidtumor, #genetics, #informatics, #infectiousdisease, or #hematopathology

Submission is free: https://www.editorialmanager.com/jmdi/default2.aspx

Consider @jmdiagn.bsky.social for publication of your next #molpath #moldx advancements. JMD is the official journal of
@ampath.bsky.social. #SolidTumor #InfectiousDisease #Informatics #Hematopathology #Genetics

Submission is free!

www.editorialmanager.com/jmdi/default...

This article on the topic of smaller format ADCs for solid tumor treatment is getting quite a bit attention recently. Check it out!

#ADC #Oncology #SolidTumor
@antibodytx.bsky.social

Health Canada, European Commission Approve Subcutaneous Nivolumab in the Same Solid Tumor Indications as IV Formulation
#SolidTumor #Oncology
www.onclive.com/view/health-...